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Abstract  
Objective: Studies have started to question whether a specific component or combinations of 
metabolic syndrome (MetS) components may be more important in relation to cardiovascular 
disease risk. Our aim was to examine the impact of the presence of raised fasting glucose as a 
MetS component on postprandial lipaemia.  
Methods: Men classified with the MetS underwent a sequential test meal investigation, in 
which blood samples were taken at regular intervals after a test breakfast (t=0 min) and lunch 
(t=330 min). Lipids, glucose and insulin were measured in the fasting and postprandial 
samples. 
Results: MetS subjects with 3 or 4 components were subdivided into those without (n=34) 
and with (n=23) fasting hyperglycaemia (≥ 5.6 mmol/l), irrespective of the combination of 
components. Fasting lipids and insulin were similar in the two groups, with glucose 
significantly higher in the men with glucose as a MetS component (P<0.001). Following the 
test meals, there was a higher maximum concentration (maxC), area under the curve (AUC) 
and incremental AUC (P≤0.016) for the postprandial triacylglycerol (TAG) response in men 
with fasting hyperglycaemia. Greater glucose AUC (P<0.001) and insulin maxC (P=0.010) 
was also observed in these individuals after the test meals. Multivariate regression analysis 
revealed fasting glucose to be an important predictor of the postprandial TAG and glucose 
response. 
Conclusion: Our data analysis has revealed a greater impairment of postprandial TAG than 
glucose response in MetS subjects with raised fasting glucose. The worsening of postprandial 
lipaemic control may contribute to the greater CVD risk reported in individuals with MetS 
component combinations which include hyperglycaemia.  
 
Keywords: postprandial state; non-esterified fatty acids; sequential test meal protocol  
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Abbreviations: AUC, area under the curve; BMI, body mass index; CVD, cardiovascular 
disease; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model 
assessment of insulin resistance; IAUC, incremental AUC; maxC, maximum concentration; 
MetS, metabolic syndrome; minC, minimum concentration; LDL-C, low-density lipoprotein 
cholesterol; NEFA, non-esterified fatty acids; TAG, triacylglycerol; TRL, TAG-rich 
lipoprotein.  
4 
 
1. Introduction 
Coupled with the increasing prevalence of overweight and obesity, 20-25% of adults are now 
classified with the metabolic syndrome (MetS) which is associated with an increased risk of 
cardiovascular disease (CVD) and type II diabetes. Studies have started to question whether a 
specific component or combinations of MetS components are associated with a greater 
relative risk of CVD than presenting with the syndrome per se [1-6]. Three- and four-
component combinations highly associated with all cause mortality and cardiovascular events 
include both abdominal obesity and hyperglycaemia, with the addition of either elevated 
triacylglycerol (TAG) or blood pressure [2,5]. Pigna and co-workers [7] reported elevated 
TAG and glucose to be independent predictors of the presence of atherosclerotic plaques. 
These findings indicate that fasting hyperglycaemia may be an important MetS component in 
relation to CVD risk.  
Dysregulation of TAG in the postprandial state has been associated with insulin 
resistance, and increasingly recognised as an independent CVD risk factor [8]. Using the 
DISRUPT database, we have shown a linear trend between the possession of increasing 
numbers of MetS components and the magnitude of the postprandial TAG and glucose 
responses [9], with an overall worsening of postprandial lipaemic control in men with 3 and 
4/5 components. In the present study, we examined the impact of fasting hyperglycaemia as a 
MetS component on postprandial TAG, non-esterified fatty acids (NEFA), glucose and 
insulin responses in men classified with the MetS.  
 
2. Methods 
The men included in this DISRUPT dataset (n=57) were from sequential meal postprandial 
study conducted using the same test meal protocol at the University of Reading between 1997 
and 2007. Briefly, these men were non-smokers, free of CVD and diabetes and were not 
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taking medication known to modify blood lipids or blood pressure [10]. The studies were 
given a favourable opinion for conduct by the University of Reading Research Ethics 
Committee and the West Berkshire Health Authority Ethics Committee, and written informed 
consent was obtained before the studies began. 
 Subjects were asked to abstain from alcohol and organized exercise regimens on the 
day prior to the postprandial investigation, and provided with a low-fat evening meal (< 10 g 
fat). After an overnight fast, subjects consumed a standard test breakfast (4.2 MJ energy, 51 g 
fat, 125 g carbohydrate and 19 g protein) and lunch (2.6 MJ energy, 30 g fat, 79 g 
carbohydrate and 15 g protein) at 0 and 330 min respectively, with blood samples taken 
before and at regular intervals until 480 min after the breakfast. No other food or drink except 
for water and decaffeinated, sugar-free drinks was allowed during the study day. 
Fasted high-density lipoprotein cholesterol (HDL-C) was determined in the 
supernatant following precipitation with dextran-manganese chloride reagent and low-density 
lipoprotein cholesterol (LDL-C) was estimated using the Friedewald formula. Plasma lipids 
and glucose were analysed with an automated analyser (Instrumentation Laboratory (UK) 
Ltd) using kits supplied by Instrumentation Laboratory and Alpha Laboratories (UK). Insulin 
was measured by ELISA (Dako Ltd, UK). The homeostasis model assessment of insulin 
resistance (HOMA-IR) was calculated using fasting glucose and insulin concentrations [11]. 
 Classification of the MetS was defined retrospectively using the National Cholesterol 
Education Program Adult Treatment Panel III and International Diabetes Federation 
definitions [12,13]. As previously described, body mass index (BMI) was used as a substitute 
for waist circumference [9]. The five MetS components therefore included BMI ≥ 25.7 
kg/m
2
, fasting glucose ≥ 5.6 mmol/l, TAG ≥ 1.7 mmol/l, HDL-C < 1.03 mmol/l and 
hypertension (systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 90 mmHg). 
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Data were analysed using SAS Software, version 9.1.3 (SAS Institute, N.C., USA). Results 
are presented in the table as mean values ± SD and in the figure as mean values ± SEM. 
Summary measures of the postprandial response include area under the curve (AUC), 
incremental AUC (IAUC) and maximum concentration (maxC). For the NEFA response, 
minimum concentration (minC) was also calculated. An Independent Samples t-test 
determined differences in baseline characteristics and postprandial summary measures 
between those with and without raised glucose as a MetS component.  Multiple regression 
analysis was used to determine the independent associations between the MetS components 
(BMI, blood pressure, fasting TAG, HDL-C and glucose) and the summary measures of the 
postprandial TAG, glucose and NEFA responses. Partial Eta-squared values were calculated 
to determine the percentages of variation in summary measures explained by the MetS 
components. P≤0.05 was taken as significant. 
 
3. Results 
Table 1 summarises baseline characteristics and postprandial summary measures in the group 
as a whole and according to the presence or absence of glucose as a MetS component. Age, 
BMI, blood pressure and fasting lipids were not different between the groups with and 
without fasting hyperglycaemia. By definition, glucose concentrations were significantly 
higher in men with glucose as a MetS component (P<0.001), but insulin and HOMA-IR were 
not different between the two groups.  
 Although fasting TAG concentrations were not significantly different, a greater 
postprandial TAG response was evident in men with fasting hyperglycaemia, which was 
reflected in the significantly greater maxC (31%), AUC (26%) and IAUC (44%)(Fig. 1a and 
Table 1). There was a biphasic pattern in the glucose response after the meals, with glucose 
concentrations falling below baseline levels before ingestion of the second meal (Fig. 1b). 
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Men with glucose as a MetS component had a significantly greater AUC (8%) for the glucose 
response, but the IAUC was similar in the two groups (Table 1). Differences were not 
apparent between groups for the NEFA response. 
 Insulin was only measured in a subset of men in the postprandial state (n=18/57). A 
significantly greater insulin maxC (59%) was reached after breakfast in men with fasting 
hyperglycaemia, with similar insulin responses in the two groups after the second meal (Fig. 
1c). AUC and IAUC were not different between the groups (Table 1). 
 
Multivariate regression analysis 
Fasting TAG and glucose were positively associated with TAG AUC (TAG P=0.002 and 
glucose P=0.024) and maxC (TAG P=0.041 and glucose P=0.035) whereas BMI was 
inversely associated with the AUC (P=0.0027), IAUC (P=0.003) and maxC (P=0.0002). 
Systolic blood pressure was negatively associated with TAG IAUC (P=0.044).  
 Significant independent predictors of the magnitude of the postprandial TAG response 
(AUC and maxC) were fasting TAG, BMI and glucose, accounting for 15.8%, 14.7% and 
8.7% of the variance in AUC and 7.1%, 21.2% and 7.5% of the variance in maxC 
respectively. BMI was the best predictor of the TAG IAUC accounting for 14.4% of the 
variance, with systolic blood pressure explaining 7.0% of the variation in this summary 
measure.  
 Only fasting glucose was independently associated with the postprandial glucose 
response, explaining 20% of the variance in both the AUC (P=0.0013) and IAUC 
(P=0.0014). For the NEFA response, fasting HDL-C was positively associated with NEFA 
maxC (P=0.0039, Partial Eta-Square 13.7%). 
 
4. Discussion 
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Our multivariate regression analysis has revealed both confirmatory and novel observations 
with respect to the impact of individual MetS components on postprandial lipaemia. In 
agreement with the literature, fasting TAG and BMI were found to be independent predictors 
of the postprandial TAG response, and fasting glucose the postprandial glucose response in 
men. Novel findings include the independent association between fasting glucose with TAG 
AUC and maxC. Specific combinations of MetS components which include hyperglycaemia 
have been considered to confer a greater CVD risk, but mechanisms underlying these 
associations are lacking.  
Although an exaggerated postprandial TAG response has often been observed in 
individuals with the MetS [14,15], our study has revealed a reduced ability to handle dietary 
TAG during the postprandial phase in men with raised fasting glucose as a MetS component 
compared to those without. Most notably, a marked increase in the postprandial TAG IAUC 
was observed, with divergence in the incremental responses as early as 180 min after the 
breakfast meal. Higher TAG concentrations after the second meal, and especially at the end 
of the postprandial investigation (53% higher at 480 min), suggests a delayed clearance of 
TAG-rich lipoproteins (TRL) and/or increased production of TRL by the liver (very low 
density lipoproteins) and intestine (chylomicrons)[16,17]. The lack of an effect of the 
possession of elevated glucose as a MetS component on the postprandial changes in NEFA, a 
substrate for TRL-TAG synthesis [18], suggests that a reduced activation of lipoprotein lipase 
or resistance to the inhibitory actions of insulin on TRL release from the liver and intestine, 
may have contributed to the greater postprandial TAG response.  
Our findings indicate that postprandial glucose handling was not impaired in MetS 
subjects with raised fasting glucose since incremental glucose responses were similar in the 
two groups. These observations are in contrast to previous studies which have shown greater 
post-challenge glucose concentrations after an oral glucose tolerance test in pre-diabetic 
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individuals with higher fasting glucose levels [19]. The use of sequential composite meals, as 
opposed to ingestion of a glucose drink alone, represents a more physiological scenario since 
the fat and protein content of a meal is known to influence the rate of gastric emptying and 
gut hormone secretion. In our men with hyperglycamia, the higher fasting glucose 
concentrations may reflect a loss of suppression of hepatic gluconeogenesis, attributable to 
lower insulin sensitivity. Although fasting insulin was only available in a subset of men 
(n=41/57), a tendency for a higher HOMA-IR was evident in men with fasting 
hyperglycaemia but this did not reach significance. However, after the breakfast meal, there 
was a marked rise in insulin concentrations in these men (59% higher maxC in our subgroup 
analysis), which we speculate may be an early indicator of a worsening insulin sensitivity. 
The additional postprandial insulin secretion after the test breakfast may have been sufficient 
to compensate for the loss of postprandial insulin sensitivity with respect to the glucose and 
NEFA response, but insufficient to have normalised the TAG response. 
 In conclusion, our data analysis suggests possession of raised fasting glucose as a 
MetS component has a greater impact on the postprandial TAG than glucose response. The 
worsening of postprandial lipaemic control may represent the crucial metabolic defect linking 
MetS hyperglycaemia with greater CVD risk. Further studies are warranted to confirm these 
associations and determine the underlying mechanisms of how abnormalities in fasting 
glucose (and/or insulin) control in the MetS can impact on TAG handling during the 
postprandial phase.    
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Table 1: Subject characteristics and postprandial summary measures for the lipid, glucose and insulin responses in the whole group of men and 
according to the presence of fasting glucose as a MetS component 
 All MetS component combinations  
 (n=57) without glucose (n=34) with glucose (n=23) P= 
Subject characteristics     
  Age (y) 54 ± 10 54 ± 11 55 ± 9 0.888 
  BMI (kg/m
2
) 27.6 ± 2.3 27.8 ± 1.8 27.2 ± 2.8 0.271 
  Blood pressure (mmHg)     
    Systolic 141 ± 19 141 ± 15 142 ± 25 0.393 
    Diastolic 88 ± 10 89 ± 9 87 ± 11 0.495 
Fasting biochemical data     
  Total cholesterol (mmol/l) 6.49 ± 0.9 6.37 ± 0.9 6.67 ± 0.9 0.224 
  HDL-C (mmol/l) 1.05 ± 0.2 1.01 ± 0.2 1.10 ± 0.2 0.182 
  LDL-C (mmol/l) 4.35 ± 0.9 4.29 ± 0.9 4.43 ± 0.9 0.563 
  TAG (mmol/l) 2.37 ± 0.7 2.28 ± 0.6 2.52 ± 0.8 0.308 
  NEFA (µmol/l) 486 ± 142 485 ± 142 486 ± 146 0.907 
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  Glucose (mmol/l) 5.48 ± 0.5 5.17 ± 0.3 5.93 ± 0.3 <0.001 
  Insulin (pmol/l)
§
 53.4 ± 28.3 50.9 ± 26.9 56.4 ± 30.2 0.507 
  HOMA-IR
§
 1.90 ± 1.1 1.70 ± 0.9 2.13 ± 1.2 0.163 
Postprandial TAG data     
  MaxC (mmol/l) 4.49 ± 1.7 4.00 ± 1.1 5.22 ± 2.0 0.014 
  AUC (mmol/l x 480 min) 1586 ± 537 1434 ± 406 1810 ± 682 0.016 
  IAUC (mmol/l x 480 min) 442 ± 244 375 ± 179 540 ± 294 0.016 
Postprandial NEFA data     
  MinC (µmol/l) 119 ± 12 120 ± 105 117 ± 60 0.757 
  MaxC (µmol/l) 744 ± 215 738 ± 247 752 ± 160 0.536 
  AUCminC (mmol/l x min) 158 ± 53 156 ± 62 161 ± 38 0.445 
  IAUCminC (mmol/l x min) 114 ± 31 111 ± 31 118 ± 32 0.398 
Postprandial glucose data     
  MaxC (mmol/l) 9.37 ± 1.0 9.18 ± 1.0 9.67 ± 1.1 0.082 
  AUC
 
(mmol/l x 480 min) 3204 ± 275 3098 ± 250 3360 ± 236 <0.001 
  IAUC (mmol/l x 480 min) 575 ± 262 616 ± 267 516 ± 248 0.159 
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Postprandial insulin response
†
    
  MaxC (pmol/l) 736 ± 291 568 ± 172 903 ± 296 0.010 
  AUC
 
(nmol/l x 480 min) 132 ± 45 119 ± 42 145 ± 46 0.215 
  IAUC (nmol/l x 480 min) 108 ± 42 99 ± 41 117 ± 43 0.371 
Values represent mean ± SD. Abbreviations: AUC, area under the curve; BMI, body mass index; HDL-C, high density lipoprotein cholesterol; 
HOMA-IR, homeostasis model of assessment-insulin resistance (fasting glucose (mmol/l) x fasting insulin (mU/L)/22.5); IAUC, incremental 
AUC; maxC, maximum concentration; minC, minimum concentration; LDL-C, low density lipoprotein cholesterol; NEFA, non-esterified fatty 
acids; TAG, triacylglycerol. For the NEFA response, AUC and IAUC were calculated from minC. 
§
The fasting insulin and HOMA data reflects 
a subset of the group for men in the group as a whole (n=41/57) without glucose (n=22/34) and with raised glucose (n=19/23) as a MetS 
component. 
†
The postprandial insulin data is derived from a subset of n=18/57 men in the group as a whole, n=9/34 men without glucose and 
n=9/23 with raised glucose as a MetS component. 
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FIGURE LEGEND 
Figure 1: Mean ± SEM for the incremental a) triacylglycerol (TAG), b) glucose and c) 
insulin responses after consumption of a test breakfast (51 g fat, 0 min) and lunch (30 g fat at 
330 min) in men without (open circles; TAG and glucose n=34 and insulin n=9) and with 
(closed circles; TAG and glucose n=23 and insulin n=9) glucose as a MetS component. The 
dashed line represents the timing of the test lunch (330 min). 
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